Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →News topic
ATC group N02AE01
Current shortage notices for the ATC group N02AE01, structured by product, country and reporting period.
17 noticesWhat the N02AE01 notices indicate for the supply chain
The 17 consolidated notices from Germany, Czechia, Austria are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
GDP-capable pharmaceutical storage in Cheb
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Buprenorphin-ratiopharm 52,5 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin-ratiopharm 35 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin AWD Matrix 70 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →BUPRENORFIN STADA 40MCG/H TDR EMP 4
Active ingredient: BUPRENORFIN
View notice details →Buprenorphin ratiopharm 20 Mikrogramm/h transdermales Pflaster
Active ingredient: BUPRENORPHIN
View notice details →Buprenorphin AL 30 Mikrogramm/Stunde transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin AL 20 Mikrogramm/Stunde transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →BUPRENORFIN MYLAN 52,5MCG/H TDR EMP 5
Active ingredient: BUPRENORFIN
View notice details →Buprenorphin ratiopharm 5 Mikrogramm/h transdermales Pflaster
Active ingredient: BUPRENORPHIN
View notice details →Buprenorphin ratiopharm 10 Mikrogramm/h transdermales Pflaster
Active ingredient: BUPRENORPHIN
View notice details →BUPRENORFIN MYLAN 35MCG/H TDR EMP 5
Active ingredient: BUPRENORFIN
View notice details →BUPRENORFIN MYLAN 70MCG/H TDR EMP 5
Active ingredient: BUPRENORFIN
View notice details →BUPRENORFIN STADA 40MCG/H TDR EMP 4
Active ingredient: BUPRENORFIN
View notice details →Buprenorphin AL 30 Mikrogramm/Stunde transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin AL 20 Mikrogramm/Stunde transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →